Walleye Capital’s Twist Bioscience TWST Stock Holding History

Walleye Capital’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,500	Closed	-$47.6K	–	5003
2025 Q4	$47.6K	Buy	+1,500	New	+$46.8K	﹤0.01%	4089
2025 Q1	–	Sell	-1,000	Closed	-$46.5K	–	5156
2024 Q4	$46.5K	Buy	+1,000	New	+$45.2K	﹤0.01%	4375
2024 Q3	–	Sell	-1,300	Closed	-$64.1K	–	5893
2024 Q2	$64.1K	Buy	+1,300	New	+$53K	﹤0.01%	4865
2024 Q1	–	Sell	-1,600	Closed	-$59K	–	5907
2023 Q4	$59K	Sell	1,600 -7,700	-83%	-$178K	﹤0.01%	4252
2023 Q3	$188K	Sell	9,300 -9,300	-50%	-$204K	﹤0.01%	3594
2023 Q2	$381K	Buy	18,600 +18,100	+3,620%	+$271K	﹤0.01%	2636
2023 Q1	$7.54K	Buy	+500	New	+$11K	﹤0.01%	3583

Other funds holding TWST

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Walleye Capital's TWST Position: Q3 2024 in Review

Walleye Capital sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 1,013 shares — an estimated $49.9K sold.

Walleye Capital first reported a position in TWST in Q4 2020 and held it in 5 quarters. The position peaked at $1.24M in Q1 2023. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

Walleye Capital reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
Walleye Capital sold 1,013 Twist Bioscience shares in Q3 2024, an estimated $49.9K.
Walleye Capital first reported a position in Twist Bioscience in Q4 2020 and held it in 5 quarters.
Walleye Capital's Twist Bioscience position peaked at $1.24M in Q1 2023.
245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.